Works matching DE "ANTINEOPLASTIC combined chemotherapy protocols"

Results: 392
    1
    2
    3
    4

    Outcomes of T-cell/histiocyte-rich large B-cell lymphoma treated with higher-intensity therapy in the rituximab era: insights from a retrospective analysis.

    Published in:
    Leukemia & Lymphoma, 2025, v. 66, n. 7, p. 1276, doi. 10.1080/10428194.2025.2465553
    By:
    • Luttwak, Efrat;
    • Robin, Edith Tama;
    • Drill, Esther;
    • Boardman, Alexander;
    • Caron, Philip;
    • Epstein-Peterson, Zachary;
    • Falchi, Lorenzo;
    • Ghione, Paola;
    • Hamlin, Paul A.;
    • Horwitz, Steven M.;
    • Intlekofer, Andrew M.;
    • Johnson, William;
    • Kumar, Anita;
    • Lue, Jennifer;
    • Noy, Ariela;
    • Owens, Colette;
    • Palomba, Maria Lia;
    • Steiner, Raphael;
    • Stuver, Robert;
    • Torka, Pallawi
    Publication type:
    Article
    5

    The survival impact of preoperative FOLFOX for resectable locally advanced rectal cancer: the R-NAC-01 study.

    Published in:
    Surgery Today, 2022, v. 52, n. 8, p. 1134, doi. 10.1007/s00595-021-02447-7
    By:
    • Ichikawa, Nobuki;
    • Homma, Shigenori;
    • Funakoshi, Tohru;
    • Hattori, Masahiro;
    • Sato, Masanori;
    • Kamiizumi, You;
    • Omori, Kazuyoshi;
    • Nomura, Masaru;
    • Yokota, Ryoichi;
    • Koike, Masahiko;
    • Kon, Hirofumi;
    • Takeda, Keisa;
    • Ishizu, Hiroyuki;
    • Matsuoka, Shinichi;
    • Hirose, Kunihiro;
    • Ishikawa, Takahisa;
    • Murata, Ryohei;
    • Iijima, Hiroaki;
    • Yoshida, Tadashi;
    • Minagawa, Nozomi
    Publication type:
    Article
    6
    7
    8
    9
    10
    11
    12

    The efficacy and safety of FOLFOX therapy for advanced esophageal squamous cell carcinoma.

    Published in:
    Scientific Reports, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41598-025-92657-7
    By:
    • Shiraishi, Kazuhiro;
    • Okada, Mao;
    • Yamamoto, Shun;
    • Matsubara, Yuki;
    • Masuishi, Toshiki;
    • Shimozaki, Keitaro;
    • Yamamoto, Yoshiyuki;
    • Hirose, Suguru;
    • Sugiyama, Keiji;
    • Furuta, Mitsuhiro;
    • Machida, Nozomu;
    • Takahashi, Naoki;
    • Yoshii, Takako;
    • Kito, Yosuke;
    • Tsuzuki, Takao;
    • Boku, Shogen;
    • Tsuchihashi, Kenji;
    • Sugaya, Akinori;
    • Takayama, Toshizo;
    • Komori, Azusa
    Publication type:
    Article
    13
    14
    15
    16
    17
    18
    19
    20

    Pegfilgrastim Prophylaxis Is Effective in the Prevention of Febrile Neutropenia and Reduces Mortality in Patients Aged ≥ 75 Years with Diffuse Large B-Cell Lymphoma Treated with R-CHOP: A Prospective Cohort Study.

    Published in:
    Cancer Research & Treatment, 2022, v. 54, n. 4, p. 1268, doi. 10.4143/crt.2021.1168
    By:
    • Seong Hyun Jeong;
    • Seok Jin Kim;
    • Dok Hyun Yoon;
    • Yong Park;
    • Hye Jin Kang;
    • Youngil Koh;
    • Gyeong-Won Lee;
    • Won-Sik Lee;
    • Deok-Hwan Yang;
    • Young Rok Do;
    • Min Kyoung Kim;
    • Kwai Han Yoo;
    • Yoon Seok Choi;
    • Hwan Jung Yun;
    • Jun Ho Yi;
    • Jae-Cheol Jo;
    • Hyeon-Seok Eom;
    • Jae-Yong Kwak;
    • Ho-Jin Shin;
    • Byeong Bae Park
    Publication type:
    Article
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41

    Comparative efficacy of adjuvant FOLFOX vs. FLOT following neoadjuvant FLOT in patients with locally advanced gastric cancer.

    Published in:
    Turkish Journal of Medical Sciences, 2025, v. 55, n. 3, p. 547, doi. 10.55730/1300-0144.6002
    By:
    • CEYLAN, Furkan;
    • ŞENER DEDE, Didem;
    • EFİL, Safa Can;
    • TENEKECİ, Ateş Kutay;
    • CEYLAN, Eren Göktuğ;
    • SEKMEK, Serhat;
    • ÇAKMAK, Mehmet;
    • BİLGİN, Burak;
    • YÜCEL, Şebnem;
    • TATLI DOĞAN, Hayriye;
    • ŞENDUR, Mehmet Ali Nahit;
    • AKINCI, Muhammed Bülent;
    • UNCU, Doğan;
    • YALÇIN, Bülent
    Publication type:
    Article
    42
    43
    44
    45
    46
    47
    48

    A non-randomized risk-adjusted comparison of lenalidomide + R-CHOP versus R-CHOP for MYC-rearranged DLBCL patients.

    Published in:
    Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00854-2
    By:
    • de Jonge, A. Vera;
    • van Werkhoven, Erik;
    • Dinmohamed, Avinash G.;
    • Nijland, Marcel;
    • Zwinderman, Aeilko H.;
    • Bossuyt, Patrick M.;
    • Veldhuis, Martine S.;
    • Rutten, Emma G. G. M.;
    • Mous, Rogier;
    • Vermaat, Joost S. P.;
    • Sandberg, Yorick;
    • de Jongh, Eva;
    • Bilgin, Yavuz M.;
    • Boersma, Rinske;
    • Koene, Harry;
    • Kersten, Marie José;
    • de Jong, Daphne;
    • Chamuleau, Martine E. D.
    Publication type:
    Article
    49

    Patients in complete remission after R-CHOP(-like) therapy for diffuse large B-cell lymphoma have limited excess use of health care services in Denmark.

    Published in:
    Blood Cancer Journal, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41408-022-00614-8
    By:
    • Jakobsen, Lasse Hjort;
    • Øvlisen, Andreas Kiesbye;
    • Severinsen, Marianne Tang;
    • Bæch, Joachim;
    • Kragholm, Kristian Hay;
    • Glimelius, Ingrid;
    • Gang, Anne Ortved;
    • Jørgensen, Judit Mészáros;
    • Frederiksen, Henrik;
    • Poulsen, Christian Bjørn;
    • Clausen, Michael Roost;
    • Pedersen, Per Trøllund;
    • Pedersen, Robert Schou;
    • Torp-Pedersen, Christian;
    • Eloranta, Sandra;
    • El-Galaly, Tarec Christoffer
    Publication type:
    Article
    50